Epworth HealthCare

Australia’s Victorian Department of Health engages Altera’s dbMotion to deliver state-wide Health Information Exchange solution

Retrieved on: 
Thursday, May 11, 2023
Data Management, Health, Technology, Health Technology, Software, General Health, HIE, Sunrise, Allscripts, Barwon Health, Health information exchange, Digital health, United Kingdom, Epworth HealthCare, Nursing

Altera Digital Health (formerly the Allscripts Hospitals and Large Physician Practices business segment) has won a competitive tender to deliver the Victorian Department of Health’s state-wide Health Information Exchange (HIE) solution.

Key Points: 
  • Altera Digital Health (formerly the Allscripts Hospitals and Large Physician Practices business segment) has won a competitive tender to deliver the Victorian Department of Health’s state-wide Health Information Exchange (HIE) solution.
  • It seeks to address one of the biggest challenges in healthcare – the sharing of health information across disparate systems for clinical care.
  • The platform supports Victoria’s digital health roadmap, which prioritizes the availability of patient health information across acute care providers.
  • Altera’s dbMotion solution has already partnered with South Western Sydney Primary Health Network, the first Asia-Pacific implementation of the solution.

Contraline Announces Acceptance of Abstracts to be Presented at 2023 American Urology Association and European Association of Urology Annual Meetings

Retrieved on: 
Wednesday, April 26, 2023
Health, Other Health, General Health, Clinical Trials, Research, Science, Biotechnology, No-scalpel vasectomy, Abstract, Male, Reproductive medicine, MBBS, ADAM, AUA, Birth, Clinical trial, Vasectomy, American Urological Association, Doctor of Philosophy, Royal Melbourne Hospital, Epworth HealthCare, MD, Patient, Azoospermia, European Association of Urology, Safety, EAU, Birth control, Pharmaceutical industry, FRACS, Urology

The abstracts were written and submitted by investigators leading the study, and were accepted for presentation at the two largest, annual international urology meetings, the European Association of Urology (EAU) and the American Urological Association (AUA).

Key Points: 
  • The abstracts were written and submitted by investigators leading the study, and were accepted for presentation at the two largest, annual international urology meetings, the European Association of Urology (EAU) and the American Urological Association (AUA).
  • The podium presentations by Nathan Lawrentschuk at AUA and Paul Anderson at EAU highlight the early research findings on the ADAM System.
  • Contraline, Inc. is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception.
  • The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia.

Contraline Announces First Patients Successfully Implanted in Male Contraceptive Study

Retrieved on: 
Thursday, November 10, 2022
Science, Research, Surgery, Men, Health, Medical Devices, Consumer, Clinical Trials, Birth, Reproductive health, Male, Family, Multimedia, Royal Melbourne Hospital, Man, Semen, Safety, Time, Epworth HealthCare, Vasectomy, Entrepreneurship, Human, Clinical trial, Patient, CEO, ADAM, Hospital, Ted Whitten, GV, Birth control, Urology

Contraline today announced the first hydrogel-based male contraceptive implants were performed in humans in a clinical trial.

Key Points: 
  • Contraline today announced the first hydrogel-based male contraceptive implants were performed in humans in a clinical trial.
  • The procedure marks the first patient implanted in The ADAM Study, which is being conducted under Human Research Ethics Committee approval.
  • The study was supported by Contraline in addition to the Male Contraceptive Initiative.
  • Contraline is continuing the study in Australia with the eventual goal of opening a second study with a larger group of patients in the United States.

HMA conference to look at future of Hospital at Home model in Asia

Retrieved on: 
Wednesday, September 28, 2022
Traction, Epworth HealthCare, Department, Department of Medicine – University of Pamplona, Health, Philips, NUHS, Hospital, Founder CEO, Ministry, Well-being, Ministry of Health (Singapore), Lafayette Home Hospital, Division, Dr. Jeyasekharan Hospital & Nursing Home, Senior, Singapore General Hospital, Heart failure, Hah, Patient, Medical home, CEO, Program director, Solution, Technology, Consultant, Caregiver, Mobile, MIC, MOH, FMCC, Health insurance, Medical device

This is why Hospital Management Asia is organising the Hospital@Home Asia conference, with Singapore's MOH Office for Healthcare Transformation as knowledge partner.

Key Points: 
  • This is why Hospital Management Asia is organising the Hospital@Home Asia conference, with Singapore's MOH Office for Healthcare Transformation as knowledge partner.
  • The one-day event on 25 November will delve into different aspects of hospital at home programmes with a particular focus on Singapore's MIC@Home (Mobile Inpatient Care at Home).
  • Prof Dan and Dr Montalto will be joining the first panel discussion looking at whether Hospital at Home is the future of acute medicine.
  • Registration is now open - click on this link for more information on the agenda, speakers, and to register: www.hospitalmanagementasia.com/events/hospital-at-home/.

Social Mobile and Oneview's Unique Tablet Improves Patient's and Care Team's Experience

Retrieved on: 
Tuesday, October 26, 2021
Safety, Social, RFID, Amazon, CIOS, Family, Patient, Google Play, GMS, Google mobile services, Epworth HealthCare, Netflix, Social mobility, NYU Langone Health, Friends, Oneview, Virtual visitation, USB, Meal, Education, Mobile phone

MIAMI, Oct. 26, 2021 /PRNewswire/ -- In collaboration with our strategic partners at Oneview Healthcare, Social Mobile proudly announces the production of the world's first Google Mobile Services (GMS) certified, UL60601-compliant, 22" tablet created specifically to enhance the healthcare experience for patients and care teams.

Key Points: 
  • MIAMI, Oct. 26, 2021 /PRNewswire/ -- In collaboration with our strategic partners at Oneview Healthcare, Social Mobile proudly announces the production of the world's first Google Mobile Services (GMS) certified, UL60601-compliant, 22" tablet created specifically to enhance the healthcare experience for patients and care teams.
  • More than just a tablet, this unique device was designed with core features to optimize the usability and security for healthcare practitioners and make patients more comfortable during their stay.
  • Together with Oneview, Epworth will be replacing over 1,400 legacy Windows all-in-one devices with the new Android Enterprise-powered Social Mobile 22" tablet.
  • Complying with the safety requirements and regulations for a smart hospital room, the Android Enterprise platform enables Social Mobile and Oneview's unique 22-inch tablet to run safely, reliably, securely and truly improve the patient and care team experience for healthcare systems who lead on exemplary care.

ZL-1102, Zai Lab’s Internally Developed Novel Human VH Antibody Fragment, Achieved Proof of Concept in Phase 1b Psoriasis Study

Retrieved on: 
Wednesday, October 20, 2021
Safety, University, SAN, CPP, Psoriasis, Hydrogel, Patient, NASDAQ, Time, Conference, Company, Epworth HealthCare, EDT, Skin, VH, Pharmacokinetics, News, GLOBE, Infection, Conference call, Erythema, Dynamics (music), Treatment, PASI, Vaccine, Pharmaceutical industry, Silviculture

ZL-1102 is an investigational, novel human VH antibody fragment, targeting the IL-17A cytokine and is formulated for topical use.

Key Points: 
  • ZL-1102 is an investigational, novel human VH antibody fragment, targeting the IL-17A cytokine and is formulated for topical use.
  • This study is the first demonstration of percutaneous penetration of an IL-17-directed protein and a consequential clinical response in psoriasis.
  • ZL-1102 is an investigational, novel human VH antibody fragment, targeting the IL-17A cytokine, which was generated by Crescendo Biologics proprietary Humabody VH platform.
  • Zai Lab is conducting a conference call to discuss this news on October 21 at 8 a.m. EDT.

Beacon Health System Enhances How Patients Find and Schedule Care with Kyruus’ Digital Platform

Retrieved on: 
Tuesday, June 15, 2021
Data management, Practice Management, Technology, Managed care, Other Health, Health, General Health, Other Technology, Software, Hospitals, Networks, Trauma centers, Hospitals, Memorial Hospital of South Bend, South Bend, Indiana, Epworth HealthCare, Facebook Beacon, Beacon, New York, Beacon Hospital, Geography of Indiana, Health care, Beacon Health System, Kyruus, BEACON HEALTH SYSTEM, KYRUUS

Kyruus , the leader in provider search and scheduling solutions for health systems, today announced that Beacon Health System , a leading non-profit health system serving northern Indiana and southern Michigan, has launched a new digital patient access experience through the Kyruus ProviderMatch platform.

Key Points: 
  • Kyruus , the leader in provider search and scheduling solutions for health systems, today announced that Beacon Health System , a leading non-profit health system serving northern Indiana and southern Michigan, has launched a new digital patient access experience through the Kyruus ProviderMatch platform.
  • Late last year, Beacon subsequently began a phased rollout of online scheduling through ProviderMatch DirectBook Kyruus award-winning consumer scheduling solution.
  • Beacon Health System is the largest, locally owned and operated non-profit health care system in northern Indiana and southern Michigan.
  • Beacon Bremen Hospital, Elkhart General Hospital, Beacon Granger Hospital, Memorial Hospital of South Bend, Beacon Childrens Hospital, Epworth Hospital, Franciscan Beacon Hospital, Beacon Medical Group and Beacon Health & Fitness are powered by more than 7,400 associates and 1,100 physicians.